CompareMarketResearchRequest a sample
Home / Healthcare / AI Osteoporosis Screening Tools

Healthcare · Market report

AI Osteoporosis Screening Tools Market Size, Share and Forecast 2026-2036

The global AI osteoporosis screening tools market is worth USD 74 mn in 2026 and is forecast to reach USD 386 mn by 2036, growing at a 18.0% CAGR. United States is the largest country market and Opportunistic CT is the largest by image source segment.

USD 74 mnMarket size 2026
USD 386 mnForecast 2036
18.0%CAGR 2026-2036
United StatesLargest country

Request a free sample Jump to the forecast

Report price: Starts from USD 1,999

5 segmentation views25 countries2026 to 2036 yearly forecast

Market overview

The global AI osteoporosis screening tools market is worth USD 74 mn in 2026 and is forecast to reach USD 386 mn by 2036, growing at a 18.0% CAGR. United States is the largest country market and Opportunistic CT is the largest by image source segment.

ScopeAI software that identifies low bone density and fracture risk from CT, X-ray and DXA images, including opportunistic screening of scans taken for other reasons, sold to hospitals and imaging providers.
IndustryHealthcare
Value 2025USD 62 mn
Value 2026USD 74 mn
Value 2036USD 386 mn
CAGR 2026-203618.0%
Volume 20262.91 million scans screened
Volume 203618.7 million scans screened
Average price 2026USD 25.3 per scans screened
Report priceStarts from USD 1,999
PublishedNovember 2026

Request a free sample of this report

AI Osteoporosis Screening Tools market size and forecast, 2026-2036

Exhibit 1The global AI osteoporosis screening tools market is forecast to grow from USD 74 mn in 2026 to USD 386 mn by 2036, more than five times its 2026 sizeGlobal market value in USD: 2025 base year, 2026 estimate and forecast to 2036. CAGR 2026 to 2036: 18.0%
AI Osteoporosis Screening Tools market value, 2025 to 2036Market value by year. 2025: USD 62 mn; 2026: USD 74 mn; 2027: USD 87 mn; 2028: USD 103 mn; 2029: USD 121 mn; 2030: USD 143 mn; 2031: USD 169 mn; 2032: USD 199 mn; 2033: USD 235 mn; 2034: USD 277 mn; 2035: USD 327 mn; 2036: USD 386 mn. Compound annual growth rate 2026 to 2036: 18.0%.202574 mn2026169 mn2031386 mn203618.0% CAGR

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

YearMarket value
2026USD 74 mn
2027USD 87 mn
2028USD 103 mn
2029USD 121 mn
2030USD 143 mn
2031USD 169 mn
2032USD 199 mn
2033USD 235 mn
2034USD 277 mn
2035USD 327 mn
2036USD 386 mn

AI Osteoporosis Screening Tools market segmentation

By image source

Exhibit 2Opportunistic CT is the largest segment by image source, with 46.0% of 2026 revenueEstimated share of 2026 global revenue, by image source
AI Osteoporosis Screening Tools market share by image source, 2026Share of 2026 revenue by image source. Opportunistic CT: 46.0%; X-ray and DXA analytics: 34.0%; Fracture-risk prediction software: 20.0%.Opportunistic CT46.0%X-ray and DXA analytics34.0%Fracture-risk prediction software20.0%

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Opportunistic CT46.0%58.2%USD 34 mn20.8%
X-ray and DXA analytics34.0%23.7%USD 25 mn13.8%
Fracture-risk prediction software20.0%18.1%USD 15 mn16.8%

By end user

Exhibit 3Hospitals adds the most revenue by end user, growing from USD 47 mn in 2026 to USD 234 mn by 2036Estimated revenue in USD by end user, 2026 and 2036 forecast
AI Osteoporosis Screening Tools market by end user, 2026 and 2036Revenue by end user in 2026 and 2036. Hospitals: USD 47 mn in 2026, USD 234 mn in 2036, change +396%; Imaging centres: USD 18 mn in 2026, USD 104 mn in 2036, change +488%; Screening programmes and other: USD 8.8 mn in 2026, USD 48 mn in 2036, change +440%.20262036 forecastChangeHospitals+396%47 mn234 mnImaging centres+488%18 mn104 mnScreening programmes and other+440%8.8 mn48 mn

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Hospitals64.0%60.7%USD 47 mn17.4%
Imaging centres24.0%27.0%USD 18 mn19.4%
Screening programmes and other12.0%12.4%USD 8.8 mn18.4%

By deployment

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Cloud54.0%58.0%USD 40 mn18.9%
On-premise30.0%26.0%USD 22 mn16.3%
Hybrid16.0%16.0%USD 12 mn18.0%

By clinical use

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Opportunistic screening38.0%41.0%USD 28 mn18.9%
Diagnosis support26.0%24.0%USD 19 mn17.1%
Fracture risk prediction24.0%24.0%USD 18 mn18.0%
Treatment monitoring12.0%11.0%USD 8.8 mn17.0%

By pricing model

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Per-scan fee40.0%38.0%USD 30 mn17.4%
Annual licence38.0%39.0%USD 28 mn18.3%
Enterprise agreement22.0%23.0%USD 16 mn18.5%

Top 25 countries for AI osteoporosis screening tools by revenue

Countries are ranked by revenue earned from sales in the country, not by where the product is made. The ten largest hold 82.0% of 2026 revenue and the 25 countries below together hold 94.9%.

Exhibit 4United States is the largest country market at USD 30 mn in 2026, and the three largest countries hold 55.0% of global revenueEstimated 2026 revenue in USD and share of the global market, ten largest countries
AI Osteoporosis Screening Tools market, ten largest countries in 2026Ten largest countries by 2026 revenue. United States: USD 30 mn, 40.0%; China: USD 5.9 mn, 8.0%; Japan: USD 5.2 mn, 7.0%; Germany: USD 4.4 mn, 6.0%; United Kingdom: USD 4.4 mn, 6.0%; France: USD 3.0 mn, 4.0%; Italy: USD 2.2 mn, 3.0%; Canada: USD 2.2 mn, 3.0%; Australia: USD 2.2 mn, 3.0%; Spain: USD 1.5 mn, 2.0%.United States30 mn 40.0%China5.9 mn 8.0%Japan5.2 mn 7.0%Germany4.4 mn 6.0%United Kingdom4.4 mn 6.0%France3.0 mn 4.0%Italy2.2 mn 3.0%Canada2.2 mn 3.0%Australia2.2 mn 3.0%Spain1.5 mn 2.0%

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

#CountryValue 2026Share 2026Value 2036CAGR 2026-36
1United StatesUSD 30 mn40.0%USD 156 mn18.1%
2ChinaUSD 5.9 mn8.0%USD 37 mn20.2%
3JapanUSD 5.2 mn7.0%USD 24 mn16.6%
4GermanyUSD 4.4 mn6.0%USD 22 mn17.2%
5United KingdomUSD 4.4 mn6.0%USD 22 mn17.6%
6FranceUSD 3.0 mn4.0%USD 14 mn17.1%
7ItalyUSD 2.2 mn3.0%USD 10 mn16.8%
8CanadaUSD 2.2 mn3.0%USD 11 mn17.6%
9AustraliaUSD 2.2 mn3.0%USD 12 mn18.0%
10SpainUSD 1.5 mn2.0%USD 7.3 mn17.4%
11NetherlandsUSD 0.97 mn1.3%USD 4.6 mn17.0%
12South KoreaUSD 0.97 mn1.3%USD 5.2 mn18.4%
13SwitzerlandUSD 0.79 mn1.1%USD 3.8 mn17.0%
14SwedenUSD 0.70 mn0.9%USD 3.4 mn17.0%
15BelgiumUSD 0.70 mn0.9%USD 3.4 mn17.0%
16IndiaUSD 0.70 mn0.9%USD 4.6 mn20.7%
17TaiwanUSD 0.70 mn0.9%USD 3.8 mn18.4%
18BrazilUSD 0.61 mn0.8%USD 3.7 mn19.6%
19TurkeyUSD 0.52 mn0.7%USD 3.1 mn19.6%
20PolandUSD 0.52 mn0.7%USD 2.8 mn18.3%
21DenmarkUSD 0.52 mn0.7%USD 2.5 mn17.1%
22AustriaUSD 0.52 mn0.7%USD 2.5 mn17.1%
23IsraelUSD 0.44 mn0.6%USD 2.4 mn18.4%
24MexicoUSD 0.44 mn0.6%USD 2.4 mn18.4%
25SingaporeUSD 0.44 mn0.6%USD 2.4 mn18.4%
Rest of worldUSD 3.7 mn5.1%USD 20 mn18.1%
Exhibit 5United States and China account for 50% of the USD 312 mn the market is forecast to add by 2036Forecast revenue added between 2026 and 2036 by country, in USD
AI Osteoporosis Screening Tools market, where the growth to 2036 comes fromRevenue added between 2026 and 2036. Market value 2026: USD 74 mn. United States: +USD 126 mn; China: +USD 31 mn; Japan: +USD 19 mn; United Kingdom: +USD 18 mn; Germany: +USD 17 mn; 20 other countries: +USD 85 mn; Rest of world: +USD 16 mn. Market value 2036: USD 386 mn.Market value 202674 mnUnited States+126 mnChina+31 mnJapan+19 mnUnited Kingdom+18 mnGermany+17 mn20 other countries+85 mnRest of world+16 mnMarket value 2036386 mn

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

Competitive landscape

Group 1: Global leaders

  • GE HealthCare
  • Siemens Healthineers
  • Hologic

Group 2: Regional and specialist players

  • Nanox AI
  • Bunker Hill Health
  • Echolight
  • Optasia Medical
  • Radiobotics

Research methodology

Every figure on this page comes from the research framework that we apply to all of the markets we cover. The 2025 base for the AI osteoporosis screening tools market is built from the volume sold and the price that buyers pay, and is cross-checked against the size of the wider industry the market belongs to. Where a market can be sized in more than one way, the routes are compared before a figure is set.

The forecast runs year by year from the 2025 base to 2036. Growth in each year reflects demand from the industries that buy the product, adoption of new technology, pricing, regulation and replacement cycles. Volume and price are modelled together, so revenue in each year equals volume multiplied by average price. The 2026 to 2036 compound annual growth rate of 18.0% is calculated from the resulting values.

The market is divided by image source, by end user, by deployment, by clinical use, by pricing model. The 25 largest countries are ranked by revenue earned from sales to buyers in each country, not by where the product is made. Segment values and country values add up to the market total in every year, and every report is checked for consistency before it is published.

Companies are placed in three groups: global leaders, regional and specialist players, and emerging and niche players. The groups describe how companies compete in the market. They are not a ranking and they are not market shares.

Our analysts also carry out primary research. Customized reports add interviews with key opinion leaders, such as senior executives, technical specialists and buyers, to test the assumptions behind the numbers for the question being asked.

Read the full research methodology

Frequently asked questions

How big is the AI osteoporosis screening tools market?

The global AI osteoporosis screening tools market is estimated at USD 62 mn in 2025 and USD 74 mn in 2026.

How fast will the AI osteoporosis screening tools market grow?

It is forecast to reach USD 386 mn by 2036, a compound annual growth rate of 18.0% from 2026, an increase of USD 312 mn.

Which country is the largest market for AI osteoporosis screening tools?

United States is the largest market by revenue at USD 30 mn in 2026, 40.0% of the global total. The three largest countries together hold 55.0%.

Which country is growing fastest?

Among the ten largest markets, China is growing fastest at 20.2% a year from 2026 to 2036.

Which AI osteoporosis screening tools segment is largest?

In the by image source split, Opportunistic CT is the largest segment with 46.0% of 2026 revenue.

Who are the leading AI osteoporosis screening tools companies?

Global leaders include GE HealthCare, Siemens Healthineers, Hologic.

Need the full report?

Request a sample to see the structure, tables and country detail.

Request a free sample

Related markets in Healthcare

← AI Capsule Endoscopy Reading Platform AI based Triage Tools →

All Healthcare markets →

Request a sample